ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,045.02
-0.17%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ASLAN Pharmaceuticals Ltd (ASLN)

  7. ASLAN Pharmaceuticals Ltd (ASLN) News

ASLN

ASLAN Pharmaceuticals (ASLN)

ASLAN Pharmaceuticals Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ASLN
DateTimeSourceHeadlineSymbolCompany
07/17/20247:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/17/20247:25AMGlobeNewswire Inc.ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary LiquidationNASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/15/20247:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/14/20244:46PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/12/20244:32PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/31/20244:25PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/09/20247:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/07/20247:41AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/11/20248:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
02/14/20244:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/24/20247:52AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/08/20247:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/22/20234:24PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
12/08/20234:42PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
10/27/20238:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
10/24/20238:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
10/16/20236:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
08/18/20237:33AMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
08/11/20237:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/20/20237:55AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/06/20238:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/06/20238:09AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/06/20237:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
07/03/20234:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
04/28/20237:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
04/26/20235:27PMEdgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
04/26/20234:28PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/24/20237:33AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/24/20237:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/20/20235:21PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:ASLN

Your Recent History

USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
COOP
Mr Cooper
USOTC
NBRI
North Bay Resources (PK)
NYSE
IONQ
IonQ
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
AXXA
Exxe (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
CGAC
Code Green Apparel (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads